Jallal Bahija — SEC Form 4 filings
SEC reporting owner CIK 1730038. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-15.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-29 to 2026-05-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 11,474 shares, $371,184 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 11,474 shares @ $32.35 ($371,184) in Immunocore Holdings plc, filed 2026-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunocore Holdings plc (IMCR) | CHIEF EXECUTIVE OFFICER, Director | 3 | — | 1 leg · 11,474 sh · $371,184 | 7 |
| Elevance Health, Inc. (ELV) | Director | 3 | — | — | 3 |
| ArriVent Biopharma, Inc. (AVBP) | Director | 1 | — | — | 1 |
Form 4 filings — Jallal Bahija
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-15 | 4 | Elevance Health, Inc. (ELV) | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-02-19 | 4 | Immunocore Holdings plc (IMCR) | Option exercise (M): 23,817 @ $0 · Sale (S): 11,474 @ $32.35 · Option exercise (M): 23,817 (derivative) @ $0 · Grant/award (A): 88,573 (derivative) @ $0 · Grant/award (A): 395,066 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Elevance Health, Inc. (ELV) | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-02-19 | 4 | Immunocore Holdings plc (IMCR) | Grant/award (A): 405,824 (derivative) @ $0 · Grant/award (A): 95,270 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Elevance Health, Inc. (ELV) | Grant/award (A): 388 @ $0 | EDGAR |
| 2024-02-21 | 4 | Immunocore Holdings plc (IMCR) | Grant/award (A): 281,819 (derivative) @ $0 | EDGAR |
| 2024-01-29 | 4 | ArriVent Biopharma, Inc. (AVBP) | Grant/award (A): 17,884 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1730038 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →